Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01553474 · ClinicalTrials.gov registry record
Blood and Saliva Sample Collection for AREDS 2
A clinical trial, sponsored by National Eye Institute (NEI).
- Completed
- Registry status
- 56
- Enrollment target
NCT01553474: Completed study, sponsored by National Eye Institute (NEI).
NCT01553474 is a clinical trial that has completed, run by National Eye Institute (NEI). The registered enrollment target is 56 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01553474 has completed, sponsored by National Eye Institute (NEI).
- COMPLETED
- Registry status
- 56 participants
- Enrollment target
Study Summary
Background: \- The Age-Related Eye Disease Study 2 (AREDS 2) is looking at different eye diseases. Study participants will provide blood and saliva samples. The samples will be stored for research on eye diseases. Objectives: \- To collect blood and saliva samples for AREDS 2 research. Eligibility: \- AREDS 2 research study participants. Design: * Participants will provide blood and saliva samples. * The samples will be submitted with personal and medical information. This information will be collected during the AREDS 2 procedures.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 56 participants |
| Start Date | 2012-02-24 |
| Est. Completion | 2013-02-05 |
What the finished NCT01553474 record still lists
NCT01553474 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 56 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01553474 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01553474 about?
NCT01553474 is a clinical study titled "Blood and Saliva Sample Collection for AREDS 2". Background: \- The Age-Related Eye Disease Study 2 (AREDS 2) is looking at different eye diseases. Study participants will provide blood and saliva samples. The samples will be stored for research on eye diseases. Objectives: \- To collect blood and saliva samples for AREDS 2 research. Eligibili...
What is the current status of trial NCT01553474?
This trial is currently completed. The enrollment target is 56 participants. The study started on 2012-02-24. Estimated completion is 2013-02-05.
Who is sponsoring clinical trial NCT01553474?
This trial is sponsored by National Eye Institute (NEI), which has 221 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02287428 · 56 participants · Phase 1
Personalized NeoAntigen Cancer Vaccine w RT Plus Pembrolizumab for Patients With Newly Diagnosed GBM
- NCT02923011 · 56 participants · Phase 3
Comparative Effectiveness of MRgFUS Versus CTgRFA for Osteoid Osteomas
- NCT02935283 · 56 participants
Neuroimaging and Neuropsychological Outcomes in Urea Cycle Disorders
- NCT03375866 · 56 participants · NA
Effects of Mixed Nut Consumption on Satiety and Weight Management
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI